The largest database of trusted experimental protocols

Ciliobrevin a

Manufactured by Bio-Techne
Sourced in United States

Ciliobrevin A is a chemical compound that functions as a selective inhibitor of cytoplasmic dynein, a motor protein responsible for the movement of cellular structures, including cilia and flagella. This compound can be used in research applications to study the role of cytoplasmic dynein in various cellular processes.

Automatically generated - may contain errors

4 protocols using ciliobrevin a

1

Embryo Asymmetry Disruption Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For chemical treatment, embryos were treated with final 2 μg/mL PTX for Gαi inhibition52 (link) (P2980, Sigma), 25 μg/mL SDS to disrupt asymmetry, 100 μM Ciliobrevin A to inhibit cytoplasmic AAA + ATPase dynein-dependent microtubule gliding and ATPase activity53 (link) (TOCRIS bioscience), or 10 μM BI2536 to block PLK1 activity (Selleckchem, USA) during the 8–16 cell stage for 10 min before fixation for immunofluorescence. For phalloidin staining, embryos were fixed with 3.7% paraformaldehyde for 15 min, followed by PBS wash three times with 0.1% triton, incubated with 10 unit/mL of Rhodamine-Phalloidin (Thermo Fisher Scientific) for 20 min, washed with PBS three times all at room temperature prior to imaging. The details of the reagents are also listed in Supplementary Table 8.
+ Open protocol
+ Expand
2

Inhibition of NLRP3 Inflammasome Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
We pre-treated LPS-primed iBMDMs for 1 hour with HDAC6 inhibitors 10 μM Tubastatin A (Sigma-Aldrich, Cat. no: SML0044), 30 μM Rocilinostat (Selleckchem, Cat. no: S8001), or 20 μM, or 5–40 μM Tubacin (Enzo Life Sciences, Cat. no: BML-GR362–0500), 10 μM microtubule polymerization inhibitors Colchicine (Sigma-Aldrich, Cat. no: C9754–100MG) or 10 μM Nocodazole (Sigma-Aldrich, Cat. no: M1404–2MG), or with 0.1–20 μM NLRP3 inhibitor MCC950 (CP-456773) (Cayman Chemicals Cat. no: 210826–40-7 and Sigma-Aldrich, Cat. no: PZ0280). Cytoplasmic dynein-dependent microtubule transport was inhibited using 25 μM Ciliobrevin A (TOCRIS bioscience, Cat. no. 4529). One-hour post drug pre-treatment, activation was carried out either with nigericin (30 min), dsDNA (6 hours), or TcdB (1 hour). iBMDMs were pretreated with 5 mM of 3-MA (Invivogen, Cat. no: tlrl-3ma) for 6 hours to block autophagy.
+ Open protocol
+ Expand
3

Modulation of Hedgehog Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following small molecules were used and dissolved in DMSO, ethanol, or water according to product data sheets as 1,000× stocks: cyclopamine (Cayman Chemical), SAG (Cayman chemical), Pr-8-Bromo cAMPs (sodium salt; Cayman Chemical), purmorphamine (Stemgent), GSA-10 (Tocris), palbociclib (Cayman Chemical), Torin 1, Ciliobrevin A (Tocris), and forskolin (Tocris). Small molecules were added to the cells 2 h before Hh induction and remained in the Shh CM throughout the experiment unless otherwise indicated.
+ Open protocol
+ Expand
4

Pharmacological Modulation of Ciliogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ciliobrevin A was purchased from Tocris (#4529) and MLN4924 (Pevonedistat, # HY-70062) was purchased from MedChemExpress (MCE). Paraformaldehyde (#J19943-K2) and Prolonged Diamond DAPI (#P36966) were purchased from Thermofisher. Finally, 4-hydroxytamoxifen was purchased from Sigma (#H6278) and SAG was purchased from Abcam (#ab142160). The working concentration of: a) Ciliobrevin A is 50µM, b) SAG is 1µg/ml, c) 4-hydroxytamoxifen for the ex vivo experiments is 2µg/ml and D) MLN4924 is 0.25 or 0.5μM.
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!